ASH 2022 | The PANGEA model: a novel dynamic model used to define disease progression in multiple myeloma
Irene Ghobrial
• 11 Dec 2022
Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the importance of improving methods of monitoring disease progression in multiple myeloma (MM) and shares some insights into the novel, dynamic PANGEA model. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
